Theravance Biopharma Inc reports results for the quarter ended in September - Earnings Summary

Theravance Biopharma

03/11/2021 22:59

* Theravance Biopharma Inc  TBPH.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended in
September. The mean expectation of nine analysts for the quarter
was for a loss of 56 cents per share.
* Revenue fell 27.7% to $13.19 million from a year ago; 
analysts expected $14.40 million. 
* Theravance Biopharma Inc's reported EPS for the quarter was a
loss of 48 cents​.
* The mean earnings estimate of analysts had fallen by
about 9.3% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Theravance Biopharma Inc shares had risen by 7.3% this
quarter and lost 55.3% so far this year.
* The company reported a quarterly loss of $35.31 million.
* Wall Street's median 12-month price target for Theravance
Biopharma Inc is $9.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell." 
This summary was machine generated November 3 at 10:58 p.m.
 ​All figures in US dollars unless otherwise stated